Stay updated on Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.

Latest updates to the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page
- Check6 days agoChange DetectedAdded a related topic entry for hereditary factor VIII deficiency disease and the Genetic and Rare Diseases Information Center resources.SummaryDifference0.1%

- Check13 days agoChange DetectedRemoved the Hemophilia A reference and the Genetic and Rare Diseases Information Center resource from the page.SummaryDifference0.1%

- Check20 days agoChange DetectedSite template revision updated from version v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check27 days agoChange DetectedSite revision log updated: added Revision v3.4.3 and removed Revision v3.4.2.SummaryDifference0.0%

- Check56 days agoChange DetectedAn added system revision note: Revision: v3.4.2. A funding-status notice and an older Revision: v3.4.1 were removed. These are administrative updates and do not alter the trial's core details or user-facing functionality.SummaryDifference0.3%

- Check63 days agoChange DetectedA general notice about government funding delays was added and the page revision shows v3.4.1 replacing v3.4.0 — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.